Does any body have paired end illumina data they are willing to share for the purposes of testing euler-sr? I'd prefer bacterial genomes, and am willing to sign any required non-disclosure agreements.
Thanks,
-mark
Thanks,
-mark
-
-
How about the K12 genome from CLC. It's provided for evaluation of their Genomics Workbench. They have Illumina (E. coli K12), ABI (S. suis) and Roche (E. coli K12) data sets. Click the link below saying "Alternatively, you can download the raw data here".
-
Thanks for the link... they are an interesting company.Originally posted by ScottC View Post
I should mention that I'm looking for anything but K12.Comment
-
theres about 300GB of paired end illumina data at NCBI - all Human.Comment
-
... more clarification ...
ideally bacterial or small fungal genomes. I'm working on de novo assembly, and my code isn't mature enough to handle the complicated mammalian repeat structure.Last edited by mchaisso; 07-06-2008, 09:55 PM.Comment
-
The NCBI short read archive might have some.
It certainly has some 454 FLX (paired) data, and some "Illumina GA" data for Bacteria, but unclear if it is paired.Comment
-
This is what Clive was talking about:
ftp://ftp.ncbi.nih.gov/pub/TraceDB/ShortRead/SRA000271/
40X human resequencing. All PE reads. They have been there for a month or so. (Sorry, not for bacteria...)Comment
-
Mark,
I know its not what you were asking for in this post, but if a set of 454 reads (~600k raw reads) would be useful for testing Euler-SR, I'd be happy to share those with you in exchange for a quick explanation of the output from this program
Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment